The Protective Effect of Mammalian Target of Rapamycin (mTOR) in Cisplatin Induced Nephropathy

Basit Öğe Kaydı
dc.contributor.authorTürkmen, Kültigin
dc.date.accessioned2020-03-26T17:45:55Z
dc.date.available2020-03-26T17:45:55Z
dc.date.issued2009
dc.departmentSelçuk Üniversitesien_US
dc.description.abstractCisplatin, a simple inorganic compound, has been one of the leading antitumor drugs especially for solid tumors for near 30 years. The mechanisms of cisplatin include denaturation of DNA and cell mitochondria, arresting cell cycle in the G2 phase and eventually causing apoptosis, inflammation, necrosis and death in cells. Apoptosis is a process of programmed cell death through cystein proteases named 'caspases'. Pathways of caspase-mediated apoptosis can classified as 'mitochondrial' pathway and 'death receptor' pathway Especially caspase-3 plays a crucial role in cisplatin-induced nephrotoxicity through the pathways of apoptosis. The mammalian target of rapamycin (mTOR), is a serine/threonine kinase that regulates both cell growth and cell cycle progression through the phosphotidyl 3 kinase (PI3K)/protein kinase B (Akt) signaling pathway. mTOR regulates both cell growth, cell cycle progression and angiogenesis. By targeting mTOR, the immunsuppressant and antiproliferative agent Rapamycin inhibits signals required for cell cycle progression, cell growth, cell proliferation and angiogene-sis. Angiogenesis is extremely important in tumor progression and metastasis. Although rapamycin is proapoptotic agent especially in cancers, there is an evidence that rapamycin can also have antiapoptotic properties through pleiotropic function in the regulation of cell death depending on the cell type and activation state as well as downstream targets of antiapoptotic molecules such as p53 and Bcl-2 proteins. Activation of caspase signaling pathways and dysregulation of pro- and antiapoptotic Bcl-2 proteins have been described previously. So there are links between the mTOR and caspase signaling pathways. Despite its effectiveness, the dose of cisplatin that can be administered is limited by its nephrotoxicity such as acute tubuler necrosis (ATN) causing acute renal failure (ARF). Several agents have been tested to see whether they could ameliorate or augment the nephrotoxicity of cisplatin. Therefore, we hypothesize that mTOR inhibitor rapamycin can inhibit cisplatin induced ATN and ARF through the mechanisms including PI3K/Akt signaling and mitochondrial cell death pathway by affecting apoptosis. If this hypothesis will be proved by experimental and clinical studies, the patients with solid tumors receiving cisplatin may also be treated with mTOR inhibitors to reduce cisplatin induced nephrotoxicity.en_US
dc.identifier.citationTürkmen, K., (2009). The Protective Effect of Mammalian Target of Rapamycin (mTOR) in Cisplatin Induced Nephropat. Iranian Journal of Medical Hypotheses and Ideas, 3(1), 1-7.
dc.identifier.endpage7
dc.identifier.issn1735-9104en_US
dc.identifier.issue1en_US
dc.identifier.scopusqualityN/Aen_US
dc.identifier.startpage1
dc.identifier.urihttps://hdl.handle.net/20.500.12395/24207
dc.identifier.volume3en_US
dc.indekslendigikaynakScopusen_US
dc.institutionauthorTürkmen, Kültigin
dc.language.isoenen_US
dc.relation.ispartofIranian Journal of Medical Hypotheses and Ideasen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.selcuk20240510_oaigen_US
dc.subjectCisplatinen_US
dc.subjectNephrotoxicityen_US
dc.subjectMammalian target of rapamycinen_US
dc.subjectApoptosisen_US
dc.subjectmTOR inhibitorsen_US
dc.titleThe Protective Effect of Mammalian Target of Rapamycin (mTOR) in Cisplatin Induced Nephropathyen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
4207.pdf
Boyut:
940.94 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Makale Dosyası
İndir

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu
İç Hastalıkları/Makale Koleksiyonu